Mei ML, Chu CH, Low KH, Che CM, Lo ECM. Caries arresting effect of silver diamine fluoride on dentine carious lesion with S. mutans and L. acidophilus dual-species cariogenic biofilm. Med Oral Patol Oral Cir Bucal. 2013 Nov 1;18 (6):e824-31.

 

 

doi:10.4317/medoral.18831

http://dx.doi.org/doi:10.4317/medoral.18831

 

 

1. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
PMid:17307580

 

2. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw – 2009 Update. Aust Endod J. 2009;35:119-30.
http://dx.doi.org/10.1111/j.1747-4477.2009.00213.x
PMid:19961450

 

3. Silverman SL, Landesberg R. Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review. Am J of Med. 2009;122:S33-S45.
http://dx.doi.org/10.1016/j.amjmed.2008.12.005
PMid:19187811

 

4. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415-23.
http://dx.doi.org/10.1016/j.joms.2006.10.061
PMid:17307586

 

5. Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. 2009;27:5356-62.
http://dx.doi.org/10.1200/JCO.2009.21.9584
PMid:19805682

 

6. Filleul O, Crompot E, Saussez E. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2400 patient cases. J Cancer Res Clin Oncol. 2010;136:1117-24.
http://dx.doi.org/10.1007/s00432-010-0907-7
PMid:20508948

 

7. Favia G, Pilolli GP, Maiorano E. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol. 2009;36:2780-7.
http://dx.doi.org/10.3899/jrheum.090455
PMid:19884275

 

8. Rodan GA, Fleisch HA. Bosphosphonates: mechanisms of action. J Clin Invest. 1996;97:2692-6.
http://dx.doi.org/10.1172/JCI118722
PMid:8675678 PMCid:PMC507360

 

9. Wang, J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. Journal of Oral and Maxillofacial Surgery. 2003;61:1104-7.
http://dx.doi.org/10.1016/S0278-2391(03)00328-8

 

10. Marx, RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of Oral and Maxillofacial Surgery. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1

 

11. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis\osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg. 2005;63:1567-75.
http://dx.doi.org/10.1016/j.joms.2005.07.010
PMid:16243172

 

12. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005;104:83-93.
http://dx.doi.org/10.1002/cncr.21130
PMid:15929121

 

13. Pires FR, Miranda A, Cardoso ES, Cardoso AS, Fregnani ER, Pereira CM et al. Oral avascular bone necrosis associated with chemotherapy and bisphosphonate therapy. Oral Dis 2005;11:365-9.
http://dx.doi.org/10.1111/j.1601-0825.2005.01130.x
PMid:16269027

 

14. Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P et al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 2005;32:1123-8.
http://dx.doi.org/10.1111/j.1600-051X.2005.00842.x
PMid:16212571

 

15. Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-61.
http://dx.doi.org/10.1124/jpet.102.035295
PMid:12183663

 

16. Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-61.
http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00009
PMid:16702591

 

17. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007;41:318-20.
http://dx.doi.org/10.1016/j.bone.2007.04.196
PMid:17572168

 

18. Ficarra G, Beninati F. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head Neck Pathol. 2007;1:132-40.
http://dx.doi.org/10.1007/s12105-007-0033-2
PMid:20614264 PMCid:PMC2807525

 

19. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479-91.
http://dx.doi.org/10.1359/jbmr.0707onj
PMid:17663640

 

20. Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 2009;67:75-84.
http://dx.doi.org/10.1016/j.joms.2008.12.002
PMid:19371818

 

21. Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol. 2009;30:390-5.
http://dx.doi.org/10.1016/j.amjoto.2008.07.014
PMid:19880027

 

22. Treister NS, Friedland B, Woo SB. Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:753-64.
http://dx.doi.org/10.1016/j.tripleo.2009.12.005
PMid:20303301

 

23. Williamson RA. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg. 2010;39:251-5.
http://dx.doi.org/10.1016/j.ijom.2009.11.014
PMid:20015614